• 1
    Smith DB, Mellor J, Jarvis LM et al. Variation of the hepatitis C virus 5′ non-coding region: implications for secondary structure, virus detection and typing. The International HCV Collaborative Study Group. J Gen Virol 1995; 76 (Pt 7): 17491761.
  • 2
    World Health Organization. World Health Report, Geneva, Switzerland 1996.
  • 3
    Di Bisceglie AM, Order SE, Klein JL et al. The role of chronic viral hepatitis in hepatocellular carcinoma in the United States. Am J Gastroenterol 1991; 86: 335338.
  • 4
    Fattovich G, Giustina G, Degos F et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997; 112: 463472.
  • 5
    Kiyosawa K, Sodeyama T, Tanaka E et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12 (4 Pt 1): 671675.
  • 6
    Seeff LB, Buskell-Bales Z, Wright EC et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med 1992; 327: 19061911.
  • 7
    The Global burden of Hepatitis C working Group. Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol 2004; 44: 2029.
  • 8
    Hepatitis C: global prevalence (update). Wkly Epidemiol Rec 1997; 72: 341344.
  • 9
    Poynard T, Mathurin P, Lai CL et al. A comparison of fibrosis progression in chronic liver diseases. J Hepatol 2003; 38: 257265.
  • 10
    Adler M, Goubau P, Nevens F, Van Vlierberghe H. Hepatitis C virus: the burden of the disease. Acta Gastroenterol Belg 2002; 65: 8386.
  • 11
    Jeannel D, Fretz C, Traore Y et al. Evidence for high genetic diversity and long-term endemicity of hepatitis C virus genotypes 1 and 2 in West Africa. J Med Virol 1998; 55: 9297.
  • 12
    Martinson FE, Weigle KA, Mushahwar IK, Weber DJ, Royce R, Lemon SM. Seroepidemiological survey of hepatitis B and C virus infections in Ghanaian children. J Med Virol 1996; 48: 278283.
  • 13
    Richard-Lenoble D, Traore O, Kombila M, Roingeard P, Dubois F, Goudeau A. Hepatitis B, C, D, and E markers in rural equatorial African villages (Gabon). Am J Trop Med Hyg 1995; 53: 338341.
  • 14
    Koretz RL, Abbey H, Coleman E, Gitnick G. Non-A, non-B post-transfusion hepatitis. Looking back in the second decade. Ann Intern Med 1993; 119: 110115.
  • 15
    Aach RD, Stevens CE, Hollinger FB et al. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N Engl J Med 1991; 325: 13251329.
  • 16
    Alter H, Jett B, Polito A et al. Analysis of the role of hepatitis C virus in transfusion-associated hepatitis. In: Viral Hepatitis and Liver Disease, HollingerFB, LemonSM, MargolisHS, eds. Baltimore, MD: Williams & Wilkins, 1991; 396402.
  • 17
    Hagan H, McGough JP, Thiede H, Weiss NS, Hopkins S, Alexander ER. Syringe exchange and risk of infection with hepatitis B and C viruses. Am J Epidemiol 1999; 149: 203213.
  • 18
    Tanaka E, Kiyosawa K, Sodeyama T et al. Prevalence of antibody to hepatitis C virus in Japanese schoolchildren: comparison with adult blood donors. Am J Trop Med Hyg 1992; 46: 460464.
  • 19
    Broers B, Junet C, Bourquin M, Deglon JJ, Perrin L, Hirschel B. Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995. AIDS 1998; 12: 20592066.
  • 20
    Dutta U, Raina V, Garg PK et al. A prospective study on the incidence of hepatitis B & C infections amongst patients with lymphoproliferative disorders. Indian J Med Res 1998; 107: 7882.
  • 21
    van Beek I, Dwyer R, Dore GJ, Luo K, Kaldor JM. Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study. BMJ 1998; 317: 433437.
  • 22
    Crofts N, Jolley D, Kaldor J, van Beek I, Wodak A. Epidemiology of hepatitis C virus infection among injecting drug users in Australia. J Epidemiol Community Health 1997; 51: 692697.
  • 23
    el-Ahmady O, Halim AB, Mansour O, Salman T. Incidence of hepatitis C virus in Egyptians. J Hepatol 1994; 21: 687.
  • 24
    Fabrizi F, Martin P, Dixit V et al. Acquisition of hepatitis C virus in hemodialysis patients: a prospective study by branched DNA signal amplification assay. Am J Kidney Dis 1998; 31: 647654.
  • 25
    Hepatitis C—global prevalence (update) Wkly Epidemiol Rec 2000; 75: 1819.
  • 26
    Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005; 5: 558567.
  • 27
    Hepatitis C: global prevalence. Wkly Epidemiol Rec 1997; 72: 6569.
  • 28
    Alavian SM, Ahmadzad-Asl M, Lankarani KB, Shahbabaie MA, Bahrami Ahmadi A, Kabir A. Hepatitis C infection in the general population of Iran: a systematic review. Hepat Mon 2009; 9: 211223.
  • 29
    Moyer LA, Mast EE, Alter MJ. Hepatitis C: part I. Routine serologic testing and diagnosis. Am Fam Physician 1999; 59: 7988.
  • 30
    Shah BB, Wong JB. The economics of hepatitis C. Clin Liver Dis 2006; 10: 717734.
  • 31
    Buti M, San Miguel R, Brosa M et al. Estimating the impact of hepatitis C virus therapy on future liver-related morbidity, mortality and costs related to chronic hepatitis C. J Hepatol 2005; 42: 639645.
  • 32
    El Saadany S, Coyle D, Giulivi A, Afzal M. Economic burden of hepatitis C in Canada and the potential impact of prevention. Results from a disease model. Eur J Health Econ 2005; 6: 159165.
  • 33
    Bao YP, Liu ZM. Systematic review of HIV and HCV infection among drug users in China. Int J STD AIDS 2009; 20: 399405.
  • 34
    Xia X, Luo J, Bai J, Yu R. Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis. Public Health 2008; 122: 9901003.
  • 35
    Lu J, Zhou Y, Lin X et al. General epidemiological parameters of viral hepatitis A, B, C, and E in six regions of China: a cross-sectional study in 2007. PLoS ONE 2009; 4: e8467.
  • 36
    Li L, He J, Zhao L. Epidemiologic features of viral hepatitis in Fujian. Zhonghua Liu Xing Bing Xue Za Zhi 1998; 19: 8992.
  • 37
    Zhang M, Sun XD, Mark SD et al. Hepatitis C virus infection, Linxian, China. Emerg Infect Dis 2005; 11: 1721.
  • 38
    Zhang M, Fan J, Li H et al. Alternative risk factors of HCV infection in a rural community in China. Epidemiol Infect 2010; 138: 10321035.
  • 39
    Mukhopadhyaya A. Hepatitis C in India. J Biosci 2008; 33: 465473.
  • 40
    Chung H, Ueda T, Kudo M. Changing trends in hepatitis C infection over the past 50 years in Japan. Intervirology 2010; 53: 3943.
  • 41
    D’Amelio R, Mele A, Mariano A et al. Stable low levels of hepatitis C virus infection among Italian young males over the past decade. Dig Liver Dis 2006; 38: 6465.
  • 42
    Mariano A, Scalia Tomba G, Tosti ME, Spada E, Mele A. Estimating the incidence, prevalence and clinical burden of hepatitis C over time in Italy. Scand J Infect Dis 2009; 41: 689699.
  • 43
    Waheed Y, Shafi T, Safi SZ, Qadri I. Hepatitis C virus in Pakistan: a systematic review of prevalence, genotypes and risk factors. World J Gastroenterol 2009; 15: 56475653.
  • 44
    Arthur RR, Hassan NF, Abdallah MY et al. Hepatitis C antibody prevalence in blood donors in different governorates in Egypt. Trans R Soc Trop Med Hyg 1997; 91: 271274.
  • 45
    el Gohary A, Hassan A, Nooman Z et al. High prevalence of hepatitis C virus among urban and rural population groups in Egypt. Acta Trop 1995; 59: 155161.
  • 46
    Mohamed MK, Rakhaa M, Shoeir S, Saber M. Viral hepatitis C infection among Egyptians, the magnitude of the problem: epidemiological and laboratory approach. J Egypt Public Health Assoc 1996; 71: 79112.
  • 47
    el-Sayed NM, Gomatos PJ, Rodier GR et al. Seroprevalence survey of Egyptian tourism workers for hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and Treponema pallidum infections: association of hepatitis C virus infections with specific regions of Egypt. Am J Trop Med Hyg 1996; 55: 179184.
  • 48
    McOmish F, Yap PL, Dow BC et al. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol 1994; 32: 884892.
  • 49
    Mellor J, Holmes EC, Jarvis LM, Yap PL, Simmonds P. Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. The International HCV Collaborative Study Group. J Gen Virol 1995; 76 (Pt 10): 24932507.
  • 50
    Quinti I, el-Salman D, Monier MK et al. HCV infection in Egyptian patients with acute hepatitis. Dig Dis Sci 1997; 42: 20172023.
  • 51
    Frank C, Mohamed MK, Strickland GT et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000; 355: 887891.
  • 52
    Miller FD, Abu-Raddad LJ. Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt. Proc Natl Acad Sci USA 2010; 107: 1475714762.
  • 53
    Razzaghi E, Rahimi Movaghar A, Hosseini M, Madani S, Chatterjee A. Rapid situation assessment of drug abuse in Iran. Iranian Welfare Organization and UNDCP, Tehran, Iran, 1999.
  • 54
    Triki H, Said N, Ben Salah A et al. Seroepidemiology of hepatitis B, C and delta viruses in Tunisia. Trans R Soc Trop Med Hyg 1997; 91: 1114.
  • 55
    Darwish MA, Faris R, Clemens JD, Rao MR, Edelman R. High seroprevalence of hepatitis A, B, C, and E viruses in residents in an Egyptian village in The Nile Delta: a pilot study. Am J Trop Med Hyg 1996; 54: 554558.
  • 56
    Stevens W, Kamali A, Karita E et al. Baseline morbidity in 2,990 adult African volunteers recruited to characterize laboratory reference intervals for future HIV vaccine clinical trials. PLoS ONE 2008; 3: e2043.
  • 57
    Madzime S, William MA, Mohamed K et al. Seroprevalence of hepatitis C virus infection among indigent urban pregnant women in Zimbabwe. Cent Afr J Med 2000; 46: 14.
  • 58
    Muhlberger N, Schwarzer R, Lettmeier B, Sroczynski G, Zeuzem S, Siebert U. HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality. BMC Public Health 2009; 9: 34.
  • 59
    Sweeting MJ, De Angelis D, Brant LJ, Harris HE, Mann AG, Ramsay ME. The burden of hepatitis C in England. J Viral Hepatol 2007; 14: 570576.
  • 60
    Hutchinson SJ, McIntyre PG, Molyneaux P et al. Prevalence of hepatitis C among injectors in Scotland 1989–2000: declining trends among young injectors halt in the late 1990s. Epidemiol Infect 2002; 128: 473477.
  • 61
    Hutchinson SJ, Bird SM, Goldberg DJ. Modeling the current and future disease burden of hepatitis C among injection drug users in Scotland. Hepatology 2005; 42: 711723.
  • 62
  • 63
    Bukh J, Purcell RH, Miller RH. At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide. Proc Natl Acad Sci USA 1993; 90: 82348238.
  • 64
    Davidson F, Simmonds P, Ferguson J et al. Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5′ non-coding region. J Gen Virol 1995; 76 (Pt 5): 11971204.
  • 65
    Stuyver L, Wyseur A, van Arnhem W, Hernandez F, Maertens G. Second-generation line probe assay for hepatitis C virus genotyping. J Clin Microbiol 1996; 34: 22592266.
  • 66
    Li CS, Chan PK, Tang JW. Molecular epidemiology of hepatitis C genotype 6a from patients with chronic hepatitis C from Hong Kong. J Med Virol 2009; 81: 628633.
  • 67
    Simmonds P, Alberti A, Alter HJ et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994; 19: 13211324.
  • 68
    Stuyver L, van Arnhem W, Wyseur A, Hernandez F, Delaporte E, Maertens G. Classification of hepatitis C viruses based on phylogenetic analysis of the envelope 1 and nonstructural 5B regions and identification of five additional subtypes. Proc Natl Acad Sci USA 1994; 91: 1013410138.
  • 69
    Tokita H, Okamoto H, Luengrojanakul P et al. Hepatitis C virus variants from Thailand classifiable into five novel genotypes in the sixth (6b), seventh (7c, 7d) and ninth (9b, 9c) major genetic groups. J Gen Virol 1995; 76 (Pt 9): 23292335.
  • 70
    Tokita H, Okamoto H, Tsuda F et al. Hepatitis C virus variants from Vietnam are classifiable into the seventh, eighth, and ninth major genetic groups. Proc Natl Acad Sci USA 1994; 91: 1102211026.
  • 71
    Tokita H, Shrestha SM, Okamoto H et al. Hepatitis C virus variants from Nepal with novel genotypes and their classification into the third major group. J Gen Virol 1994; 75 (Pt 4): 931936.
  • 72
    Mellor J, Walsh EA, Prescott LE et al. Survey of type 6 group variants of hepatitis C virus in Southeast Asia by using a core-based genotyping assay. J Clin Microbiol 1996; 34: 417423.
  • 73
    Ruggieri A, Argentini C, Kouruma F et al. Heterogeneity of hepatitis C virus genotype 2 variants in West Central Africa (Guinea Conakry). J Gen Virol 1996; 77 (Pt 9): 20732076.
  • 74
    Abergel A, Ughetto S, Dubost S et al. The epidemiology and virology of hepatitis C virus genotype 5 in central France. Aliment Pharmacol Ther 2007; 26: 14371446.
  • 75
    Bernier L, Willems B, Delage G, Murphy DG. Identification of numerous hepatitis C virus genotypes in Montreal, Canada. J Clin Microbiol 1996; 34: 28152818.
  • 76
    McCaw R, Moaven L, Locarnini SA, Bowden DS. Hepatitis C virus genotypes in Australia. J Viral Hepatol 1997; 4: 351357.
  • 77
    Markov PV, Pepin J, Frost E, Deslandes S, Labbe AC, Pybus OG. Phylogeography and molecular epidemiology of hepatitis C virus genotype 2 in Africa. J Gen Virol 2009; 90 (Pt 9): 20862096.
  • 78
    Dore GJ, Law M, MacDonald M, Kaldor JM. Epidemiology of hepatitis C virus infection in Australia. J Clin Virol 2003; 26: 171184.
  • 79
    Hepatitis C Virus Projections Working Group. Estimates and projections of the hepatitis C virus epidemic in Australia 2002. Darlinghurst, NSW 2010: Australian National Council on AIDS, Hepatitis C and Related Diseases. Hepatitis C Sub-Committee, Hepatitis C Virus Projections Working Group. Estimates and Projections of the Hepatitis C Virus Epidemic in Australia 2002. National Centre in HIV Epidemiology and Clinical Research. The University of New South Wales; 2002.
  • 80
    Zou S, Tepper M, El Saadany S. Prediction of hepatitis C burden in Canada. Can J Gastroenterol 2000; 14: 575580.
  • 81
    Deuffic-Burban S, Mathurin P, Valleron AJ. Modelling the past, current and future HCV burden in France: detailed analysis and perspectives. Stat Methods Med Res 2009; 18: 233252.
  • 82
    Deuffic-Burban S, Poynard T, Sulkowski MS, Wong JB. Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States. J Viral Hepatol 2007; 14: 107115.
  • 83
    Sagnelli E, Stroffolini T, Mele A et al. The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases. J Med Virol 2005; 75: 522527.
  • 84
    Kim SR, Kudo M, Hino O, Han KH, Chung YH, Lee HS. Epidemiology of hepatocellular carcinoma in Japan and Korea. A review. Oncology 2008; 75 (suppl 1): 1316.
  • 85
    Tanaka H, Imai Y, Hiramatsu N et al. Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003. Ann Intern Med 2008; 148: 820826.
  • 86
    Rosen HR, Chou S, Sasaki AW, Gretch DR. Molecular epidemiology of hepatitis C infection in US veteran liver transplant recipients: evidence for decreasing relative prevalence of genotype 1B. Am J Gastroenterol 1999; 94: 30153019.
    Direct Link:
  • 87
    Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepatol 1999; 6: 3547.
  • 88
    Alter, MJ. Epidemiology of Hepatitis C. Hepatology 1997, 26(S3): 62S65S.
  • 89
    EASL International Consensus Conference on Hepatitis C. Consensus Statement. Journal of Hepatology, 1999, 31: 38.
  • 90
    Pruss-Ustun A, Rapiti E, Hutin Y. Estimation of the global burden of disease attributable to contaminated sharps injuries among health-care workers. Am J Ind Med 2005; 48: 482490.
  • 91
    FitzSimons D, Francois G, De Carli G et al. Hepatitis B virus, hepatitis C virus and other blood-borne infections in healthcare workers: guidelines for prevention and management in industrialised countries. Occup Environ Med 2008; 65: 446451.
  • 92
    Perz JF, Thompson ND, Schaefer MK, Patel PR. US outbreak investigations highlight the need for safe injection practices and basic infection control. Clin Liver Dis 2010; 14: 137151.